Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed
Genesis HealthCare (NYSE: GEN) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.Genesis HealthCare reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.
